HLA-DRB1 and myeloid sarcoma: The HLA class II alleles, especially the haplotype DRB5*01:01-HLA-DRB1*15:01-HLA-DQA1*01:02-HLA-DQB1*06:02 confers 2–4-fold increased risk of MS [2].